| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96455 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate |
2012-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc50c56a8fe922fe6f3a821d3354fbe7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0e200f1b6e8b43aeea1eb9b5f9b939d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccbe54fe33228870e88b873512969ace
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c4ab2fce2d4aed1eda8b4ad81498c15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53fcc4112223e1e70fdf92b2e0496712 |
| publicationDate |
2016-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112013032132-A2 |
| titleOfInvention |
"use of kallikrein family peptidase, its expression-enhancing agent, or cells that have reduced rheb expression or activity for the prevention or treatment of diabetes and metabolic disorder and increased insulin sensitivity, as well as methods for determining whether it is composed of test is likely therapeutic agent in the treatment of diabetes " |
| abstract |
Patent Summary: "Methods for Increasing Insulin Sensitivity and Treatment of Diabetes". The present invention relates to methods for increasing insulin sensitivity and for treating diabetes (type i and type ii). Also described in the present invention are methods for increasing the amount of brown fat in an individual and for treating metabolic disorders, including obesity. 20018669v1 1/1 20018669v1 |
| priorityDate |
2011-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |